We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$90.5B
1-Year Est. Return
33.95%
This Fund
S&P 500
This Quarter
Est. Return
+0.29%
1 Year Est. Return
+33.95%
3 Year Est. Return
+77.62%
5 Year Est. Return
+56.06%
10 Year Est. Return
+196.47%
AUM
$85.1B
AUM Growth
-$8.87B
(-9.4%)
Cap. Flow
-$1.55B
Cap. Flow
% of AUM
-1.82%
Top 10 Holdings %
Top 10 Hldgs %
22.93%
Holding
5,158
New
966
Increased
1,586
Reduced
1,613
Closed
969
Avg Time Held Equity + Options
6.5
quarters
Top 10 Avg Time Held Equity + Options
2.6
quarters
Top 20 Avg Time Held Equity + Options
4.9
quarters
Avg Time Held Equity only
5.7
quarters
Top 10 Avg Time Held Equity only
4.6
quarters
Top 20 Avg Time Held Equity only
3.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.15B |
| 2 |
Microsoft
MSFT
|
+$516M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$363M |
| 4 |
Tesla
TSLA
|
+$252M |
| 5 |
Qualcomm
QCOM
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$291M |
| 2 |
Tapestry
TPR
|
+$220M |
| 3 |
Advanced Micro Devices
AMD
|
+$217M |
| 4 |
Netflix
NFLX
|
+$207M |
| 5 |
Amazon
AMZN
|
+$182M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.99% |
| 2 | Technology | 10.98% |
| 3 | Consumer Discretionary | 6.24% |
| 4 | Industrials | 5.32% |
| 5 | Financials | 5.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4126
OraSure Technologies
OSUR
$263M
| $45.6K | ﹤0.01% |
15,199
+1,590
| +12% | +$4.53K |
2023 Q4
9 quarters
|
|
4127
Stereotaxis
STXS
$109M
| $44K | ﹤0.01% |
+23,908
| New | +$52.4K |
2026 Q1
0 quarters
|
|
4128
Eve Holding
EVEX
$558M
| $44K | ﹤0.01% |
17,730
-181,864
| -91% | -$621K |
2025 Q4
1 quarter
|
|
4129
Agora
API
$353M
| $43.5K | ﹤0.01% |
+12,291
| New | +$52.1K |
2026 Q1
0 quarters
|
|
4130
Inovio Pharmaceuticals
INO
$109M
| $43.2K | ﹤0.01% |
+24,837
| New | +$40.9K |
2026 Q1
0 quarters
|
|
4131
Cardiff Oncology
CRDF
$78.6M
| $42.7K | ﹤0.01% |
+26,356
| New | +$54.1K |
2026 Q1
0 quarters
|
|
4132
OPAL Fuels
OPAL
$50.9M
| $42K | ﹤0.01% |
+16,653
| New | +$38.2K |
2026 Q1
0 quarters
|
|
4133
AirSculpt Technologies
AIRS
$116M
| $41.4K | ﹤0.01% |
14,637
-87,419
| -86% | -$204K |
2025 Q3
2 quarters
|
|
4134
Agenus
AGEN
$322M
| $41.3K | ﹤0.01% |
12,373
-42,769
| -78% | -$142K |
2025 Q3
2 quarters
|
|
4135
Montauk Renewables
MNTK
$339M
| $41.3K | ﹤0.01% |
+35,893
| New | +$54.1K |
2026 Q1
0 quarters
|
|
4136
Lifezone Metals
LZM
$308M
| $40.7K | ﹤0.01% |
+12,122
| New | +$56.3K |
2026 Q1
0 quarters
|
|
4137
Enel Chile
ENIC
$6.09B
| $40.7K | ﹤0.01% |
+10,335
| New | +$43K |
2026 Q1
0 quarters
|
|
4138
So-Young International
SY
$262M
| $39K | ﹤0.01% |
+14,286
| New | +$42.7K |
2026 Q1
0 quarters
|
|
4139
Health Catalyst
HCAT
$132M
| $38.7K | ﹤0.01% |
30,438
-158,240
| -84% | -$298K |
2025 Q1
4 quarters
|
|
4140
Abundia Global Impact Group
AGIG
$40M
| $38.6K | ﹤0.01% |
+26,812
| New | +$69.8K |
2026 Q1
0 quarters
|
|
4141
Acrivon Therapeutics
ACRV
$76.3M
| $38.2K | ﹤0.01% |
27,472
+1,310
| +5% | +$2.29K |
2025 Q2
3 quarters
|
|
4142
BRC Inc
BRCC
$148M
| $36.8K | ﹤0.01% |
+4,743
| New | +$39.9K |
2026 Q1
0 quarters
|
|
4143
Acumen Pharmaceuticals
ABOS
$138M
| $35.4K | ﹤0.01% |
+15,015
| New | +$38.3K |
2026 Q1
0 quarters
|
|
4144
ZenaTech Inc
ZENA
$95.1M
| $35.3K | ﹤0.01% |
+15,415
| New | +$46.7K |
2026 Q1
0 quarters
|
|
4145
Gaia
GAIA
$31.3M
| $34.9K | ﹤0.01% |
+12,585
| New | +$41.4K |
2026 Q1
0 quarters
|
|
4146
NeoVolta
NEOV
$145M
| $34.4K | ﹤0.01% |
+11,173
| New | +$43.5K |
2026 Q1
0 quarters
|
|
4147
Similarweb
SMWB
$787M
| $34K | ﹤0.01% |
+13,020
| New | +$54.3K |
2026 Q1
0 quarters
|
|
4148
PMV Pharmaceuticals
PMVP
$74.8M
| $34K | ﹤0.01% |
27,381
+879
| +3% | +$1.12K |
2024 Q2
7 quarters
|
|
4149
Black Diamond Therapeutics
BDTX
$98.2M
| $32.5K | ﹤0.01% |
15,280
+528
| +4% | +$1.26K |
2023 Q4
9 quarters
|
|
4150
Curis
CRIS
$1.56M
| $31.8K | ﹤0.01% |
2,902
-1,422
| -33% | -$26.5K |
2025 Q2
3 quarters
|
|
Similar funds
VM
Squarepoint's Q1 2026 Portfolio in Review
As of Q1 2026, Squarepoint held 5,158 positions worth $85.1B, down 9.4% from $94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Squarepoint's Q1 2026 filing shows 966 new, 1,586 increased, 1,613 reduced and 969 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 243,417 shares worth $158M. The largest sale was Broadcom, an estimated $291M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 56% a quarter earlier, followed by Technology and Consumer Discretionary.
- Squarepoint's largest Q1 2026 buy was State Street SPDR S&P 500 ETF Trust: 243,417 shares worth $158M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $1.15B increase.
- Squarepoint's biggest Q1 2026 reduction was Broadcom, cutting an estimated $291M.
- Squarepoint fully exited State Street Financial Select Sector SPDR ETF in Q1 2026, selling an estimated $114M.
- Squarepoint's ten largest holdings make up 23% of its $85.1B portfolio in Q1 2026.
- Squarepoint opened 966 new positions and closed 969 in Q1 2026.
- Squarepoint's portfolio value fell 9.4% quarter-over-quarter to $85.1B.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.